Creve Coeur, MO, United States of America

William Dean Joy

This inventor holds 1 USPTO granted patent. Top assignee: Monsanto Company. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Dean Joy. Retrieved from https://idiyas.com/inventor/william-dean-joy-nnvirzhb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: William Dean Joy: Innovator in Pharmaceutical Chemistry

Introduction

William Dean Joy is a notable inventor based in Creve Coeur, MO (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as phosphodiesterase inhibitors. His work has implications for treating various medical conditions.

Latest Patents

Joy holds a patent for "Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors." This invention provides compounds that are useful in the treatment of a variety of diseases, including glaucoma, sexual dysfunction, asthma, and cardiovascular disorders such as angina, hypertension, and thrombosis. His patent is a testament to his innovative approach to addressing complex health issues.

Career Highlights

William Dean Joy is associated with Monsanto Company, where he has been able to apply his expertise in pharmaceutical development. His work at Monsanto has allowed him to contribute to advancements in medical treatments and therapies.

Collaborations

Joy has collaborated with notable colleagues, including Horng-Chih Huang and Timothy S Chamberlain. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

William Dean Joy's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to improving health outcomes. His work continues to influence the field and offers hope for effective treatments for various diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…